These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27716818)

  • 21. Genetics and immunological recovery with antiretroviral treatment for HIV.
    Veloso Carvalho-Silva WH; Andrade-Santos JL; Dos Santos Guedes MC; Guimarães RL
    Pharmacogenomics; 2020 Sep; 21(14):979-983. PubMed ID: 32893739
    [No Abstract]   [Full Text] [Related]  

  • 22. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.
    Cid-Silva P; Margusino-Framiñán L; Balboa-Barreiro V; Pernas-Souto B; Mena-De-Cea Á; Martín-Herranz I; Castro-Iglesias Á; Poveda E
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821940. PubMed ID: 30798655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model-based prediction of CD4 cells counts in HIV-infected adults on antiretroviral therapy in Northwest Ethiopia: A flexible mixed effects approach.
    Awoke Ayele T; Worku A; Kebede Y; Zuma K; Kasim A; Shkedy Z
    PLoS One; 2019; 14(7):e0218514. PubMed ID: 31291281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
    Seyoum A; Ndlovu P; Temesgen Z
    AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.
    Miller V; Mocroft A; Reiss P; Katlama C; Papadopoulos AI; Katzenstein T; van Lunzen J; Antunes F; Phillips AN; Lundgren JD
    Ann Intern Med; 1999 Apr; 130(7):570-7. PubMed ID: 10189326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
    Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
    BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.
    De Beaudrap P; Etard JF; Diouf A; Ndiaye I; Guèye NF; Guèye PM; Sow PS; Mboup S; Ndoye I; Ecochard R; Eric D;
    Am J Trop Med Hyg; 2009 Jun; 80(6):1047-53. PubMed ID: 19478274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters.
    Guo FP; Li YJ; Qiu ZF; Lv W; Han Y; Xie J; Li YL; Song XJ; Du SS; Mehraj V; Li TS; Routy JP
    Chin Med J (Engl); 2016 Nov; 129(22):2683-2690. PubMed ID: 27824000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy.
    Sudfeld CR; Wang M; Aboud S; Giovannucci EL; Mugusi FM; Fawzi WW
    PLoS One; 2012; 7(6):e40036. PubMed ID: 22768212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study.
    Castillo-Rozas G; Tu S; Luz PM; Mejia F; Sierra-Madero J; Rouzier V; Shepherd BE; Cortes CP
    J Int AIDS Soc; 2024 Mar; 27(3):e26214. PubMed ID: 38494667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.
    García F; de Lazzari E; Plana M; Castro P; Mestre G; Nomdedeu M; Fumero E; Martínez E; Mallolas J; Blanco JL; Miró JM; Pumarola T; Gallart T; Gatell JM
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):702-13. PubMed ID: 15167289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.
    Gunda DW; Kilonzo SB; Kamugisha E; Rauya EZ; Mpondo BC
    BMC Res Notes; 2017 Jun; 10(1):197. PubMed ID: 28595630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune recovery of middle-aged HIV patients following antiretroviral therapy: An observational cohort study.
    Wong NS; Chan KCW; Cheung EKH; Wong KH; Lee SS
    Medicine (Baltimore); 2017 Jul; 96(28):e7493. PubMed ID: 28700495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART.
    Ujeneza EL; Ndifon W; Sawry S; Fatti G; Riou J; Davies MA; Nieuwoudt M;
    Elife; 2021 Jan; 10():. PubMed ID: 33443013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.